NCT01995929

Brief Summary

The esophago-gastro-duodenoscopy is an endoscopic examination technique of the upper GI-tract which was founded by the German surgeon Johann Freiherr von Mikuliicz-Radecki at the end of 19th century. By this means, the luminal site of the esophagus, stomach and duodenum may be visualized after inserting a flexible endoscope through the mouth (transoral access). By the rapid technical development in the last years smaller flexible video endoscopes have been developed allowing also an alternative access to the upper GI-tract via the nose (transnasal access). Patients with dysphagia are referred to physicians of different disciplines (gastroenterology, surgery, ear, nose, and throat (ENT) medicine, radiology, neurology) performing a variety of endoscopic and non-endoscopic techniques. Mostly, the endoscopic examination of the esophagus is done in sedated patients in left lateral examination. Typical findings during esophagoscopy might be tumors, strictures, achalasia or diverticula. Patients suffering from neurogenic dysphagia often get caught in the trap: they find themselves somewhere in the space between gastroenterologist, neurologist, ENT-specialist and radiologist. This dilemma might be due to a lack of pathophysiological knowledge among many physicians and an inability to directly visualize the esophageal phase of deglutition. In sedated patients lying in left lateral position, endoscopists may receive a very limited impression of the function of the different phases of swallowing since this endoscopic access is a rather static one. The focus of our observational study are patients with suspected neurogenic dysphagia. These patients shall be examined by transnasal endoscopy applying an ultrathin video endoscope with an outer diameter of 3.8 mm (BF-3C160, Olympus Europe). Patients are examined in sitting position while ingesting water and food of different consistencies (functional endoscopy). Diagnostic shall be completed and correlated by videofluoroscopy, high-resolution manometry and assessment of the clinical signs. Beside feasibility and safety as primary endpoints, secondary endpoints shall be the assessment of pathologic endoscopic findings in patients suffering from neurogenic dysphagia. The study is approved by the local Ethics Committee (AZ 2010-214-f-S).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 27, 2013

Completed
4 days until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2017

Completed
Last Updated

November 9, 2022

Status Verified

December 1, 2020

Enrollment Period

3.9 years

First QC Date

November 18, 2013

Last Update Submit

November 6, 2022

Conditions

Keywords

neurogenic dysphagiatransnasal endoscopyfunctional endoscopy

Outcome Measures

Primary Outcomes (1)

  • Number of patients in which the procedure may be successfully performed (feasibility)

    Feasibility, safety, and tolerability of the procedure

    30 minutes

Secondary Outcomes (2)

  • Pathologic endoscopic findings in patients suffering from neurogenic dysphagia

    30 minutes

  • Number of patients with adverse events as a measure of safety and tolerability

    1 week

Study Arms (1)

neurogenic dysphagia

Patients suffering from neurogenic dysphagia due to several reasons (e.g. Parkinson´s disease).

Procedure: transnasal functional endoscopy

Interventions

Also known as: ultrathin video endoscope with an outer diameter of 3.8 mm (BF-3C160, Olympus Europe)
neurogenic dysphagia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The focus of our observational study are patients with suspected neurogenic dysphagia.

You may not qualify if:

  • Age under 18 years
  • Inability to understand information for participation
  • Refusal of participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Josephs Hospital Warendorf

Warendorf, North Rhine-Westphalia, 48231, Germany

Location

University Hospital of Muenster

Münster, Germany

Location

Related Publications (8)

  • Cheung J, Bailey R, Veldhuyzen van Zanten S, McLean R, Fedorak RN, Morse J, Millan M, Guzowski T, Goodman KJ; CANHelp working group. Early experience with unsedated ultrathin 4.9 mm transnasal gastroscopy: a pilot study. Can J Gastroenterol. 2008 Nov;22(11):917-22. doi: 10.1155/2008/323027.

    PMID: 19018337BACKGROUND
  • Wiegand N, Bauerfeind P, Delco F, Fried M, Wildi SM. Endoscopic position control of nasoenteral feeding tubes by transnasal re-endoscopy: a prospective study in intensive care patients. Am J Gastroenterol. 2009 May;104(5):1271-6. doi: 10.1038/ajg.2009.26. Epub 2009 Mar 24.

    PMID: 19319127BACKGROUND
  • Zhihui T, Wenkui Y, Weiqin L, Zhiming W, Xianghong Y, Ning L, Jieshou L. A randomised clinical trial of transnasal endoscopy versus fluoroscopy for the placement of nasojejunal feeding tubes in patients with severe acute pancreatitis. Postgrad Med J. 2009 Feb;85(1000):59-63. doi: 10.1136/pgmj.2008.070326.

    PMID: 19329697BACKGROUND
  • Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schabitz WR, Dziewas R. Towards a basic endoscopic evaluation of swallowing in acute stroke - identification of salient findings by the inexperienced examiner. BMC Med Educ. 2009 Mar 10;9:13. doi: 10.1186/1472-6920-9-13.

    PMID: 19284543BACKGROUND
  • Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schabitz WR, Dziewas R. The safety of fiberoptic endoscopic evaluation of swallowing in acute stroke patients. Stroke. 2009 Feb;40(2):482-6. doi: 10.1161/STROKEAHA.108.520775. Epub 2008 Dec 12.

    PMID: 19074481BACKGROUND
  • Warnecke T, Teismann I, Zimmermann J, Oelenberg S, Ringelstein EB, Dziewas R. Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. J Neurol. 2008 Feb;255(2):224-30. doi: 10.1007/s00415-008-0664-6. Epub 2008 Jan 28.

    PMID: 18217186BACKGROUND
  • Herrmann IF, Scarpignato C. [Functional endoscopy : the physiological and pathophysiological basis of reflux disease, diagnosis and therapy]. HNO. 2009 Dec;57(12):1221-36. doi: 10.1007/s00106-009-1934-z. German.

    PMID: 19924362BACKGROUND
  • Ruckert J, Lenz P, Heinzow H, Wessling J, Warnecke T, Herrmann IF, Strahl M, Lenze F, Nowacki T, Domagk D. Functional endoscopy in neurogenic dysphagia: a feasibility study focusing on the esophageal phase of swallowing. Endosc Int Open. 2021 Apr;9(4):E646-E652. doi: 10.1055/a-1380-3224. Epub 2021 Apr 15.

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med. Dirk Domagk

Study Record Dates

First Submitted

November 18, 2013

First Posted

November 27, 2013

Study Start

December 1, 2013

Primary Completion

October 31, 2017

Study Completion

October 31, 2017

Last Updated

November 9, 2022

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations